INS and COVID-19: Al-Aly and colleagues [40] showed that vaccinated COVID-19 survivors had a lower risk of long COVID compared with unvaccinated COVID-19 survivors, including metabolic disorders (encompassing “diabetes,” “hyperlipidaemia,” and “insulin use” in the study; HR = 0.77 [95% CI 0.68 to 0.87]), suggesting the benefits of COVID-19 vaccination on the risk of incident diabetes following SARS-CoV-2 infection.